This may cause bloating, mild constipation, or a feeling of fullness after small amounts of food
Monitoring strategies include periodic assessment of treatment response, adjustment of protocols based on outcomes, and long-term maintenance planning
Our team is ready to guide you through your weight loss journey, customizing your treatment to ensure the best possible results
GLP-1 RAs are currently being explored for use in various new areas, such as cardiovascular disease, non-alcoholic steatohepatitis (NASH), Alzheimer's disease, and chronic kidney disease
2026;9(7):e2624382
Semaglutida oral (Rybelsus para diabetes tipo 2): Se inicia con 3 mg una vez al da durante 30 das, luego se aumenta a 7 mg diarios